Biocon allots 11.27 crore shares via QIP at Rs 368.35, raises Rs 4,150 crore
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Biocon allotted 11,26,64,585 equity shares under a Qualified Institutions Placement at Rs 368.35 per share (including a premium of Rs 363.35), raising Rs 4,150 crore. The issue was open from January 12 to 14, 2026. Major allottees were SBI MF schemes (29.5% PAN clubbed), ICICI Prudential MF schemes (29.5% PAN clubbed), and Mirae Asset MF (8.4% PAN clubbed). Paid-up equity capital rose to about Rs 810.45 crore from Rs 754.12 crore, a dilution of roughly 7%.
Equity dilution of about 7%. Short-term price pressure likely from increased supply, though marquee investor participation is a positive sign.